Resources

Successes in HIV, TB and malaria.

Resource scenarios for 2011-2013.

This note presents a series of illustrative scenarios for fulfilling the resource needs of the Global Fund for 2011−2013, having regard to patterns of donor participation in another significant replenishment mechanism, indicators of countries’ capacity to contribute and experience to date.

This paper highlights how Global Fund support to countries has contributed to progress in achieving Millennium Development Goals 4 and 5 and analyzes the impact it has had on the lives of millions of women and children.

Ensuring value for money at every stage of the financing chain is a critical priority for the Global Fund, extending from donors to the people who benefit from program services directly. This report outlines value for money at the institutional level and in grant and program implementation.

The costs and expected health impact of maintaining the support to these recipients have been projected until 2020. The projections include total program costs met by domestic contributions as well as external contributions.

This study estimates the economic returns that Global Fund-supported ARV therapy services and their associated health benefits can generate over the 11-year period 2011 to 2020. The presented new model quantifies economic returns by linking Global Fund grant delivery results with projections of the future costs of ARV therapy programs and of corresponding gains in patient survival and the economic value of life-years gained.

The summary of the impact of Global Fund programmes as of 2010.

This report is based on Global Fund results through the end of 2009.

This report covers the benefits and outcomes of private sector contributions to the Global Fund up to 2010.